Tremelimumab Biosimilar, Anti-human CTLA-4 Monoclonal Antibody

Tremelimumab biosimilar is a recombinant chimeric IgG2 kappa monoclonal antibody. The cheapest research grade tremelimumab biosimilar (anti-human CTLA-4 / CD152 monoclonal antibody) for ELISA, neutralization, in vivo functional assays such as bioanalytical PK and ADA assays, and those in vitro and in vivo assays for studying biological pathways affected by cetuximab. The research grade tremelimumab biosimilar protein is for research use only.

Synonyms: cytCTLA4, hCTLA-4, otoxic T-lymphocyte–associated antigen 4, cytotoxic T-lymphocyte antigen 4, CD152